Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
71.3M
-
Shares change
-
-4.58M
-
Total reported value, excl. options
-
$167M
-
Value change
-
-$6.98M
-
Put/Call ratio
-
0.01
-
Number of buys
-
34
-
Number of sells
-
-53
-
Price
-
$2.34
Significant Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q3 2025
103 filings reported holding CABA - Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share as of Q3 2025.
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.3M shares
of 96M outstanding shares and own 74.26% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (9.68M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (8.83M shares), JENNISON ASSOCIATES LLC (8.5M shares), T. Rowe Price Investment Management, Inc. (8.36M shares), Cormorant Asset Management, LP (5M shares), VANGUARD GROUP INC (4.19M shares), Woodline Partners LP (2.14M shares), HEIGHTS CAPITAL MANAGEMENT, INC (2.08M shares), HEIGHTS CAPITAL MANAGEMENT, INC (2.08M shares), and BlackRock, Inc. (1.62M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.